EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

GrcC1 mediates low-level resistance to multiple drugs in M. marinum , M. abscessus, and M. smegmatis

Cuiting Fang iD, Han Zhang, Jing He, Xirong Tian, Sanshan Zeng, Xingli Han, Shuai Wang, Buhari Yusuf, Jinxing Hu, Nanshan Zhong, Yamin Gao iD, H M Adnan Hameed iD und 1 weitere

Microbiology Spectrum · 2025

DOI: 10.1128/spectrum.02289-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2025. Verfasst von Cuiting Fang und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Respiratory Disease, Institute of Drug Discovery, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences…. Hauptthemen laut MEDLINE: Mycobacterium marinum, Anti-Bacterial Agents, Mycobacterium smegmatis, Bacterial Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MOST | National Key Research and Development Program of China (NKPs), State Key Laboratory of Respiratory Disease (SKLRD), Bureau of Science and Information Technology of Guangzhou Municipality | Guangzhou Municipal Science and Technology Project (Guangzhou Science and Technology P….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The escalating threat of mycobacterial infectious diseases, particularly those caused by nontuberculous mycobacteria (NTM), poses a serious challenge to public health. Linezolid (LZD), an oxazolidinone antimicrobial, exhibits potent activity against Mycobacterium tuberculosis and NTM. Generally, mutations in the rrl and rplC genes are widely associated with resistance to LZD. However, in this study, we screened Mycobacterium marinum strains lacking such mutations, indicating the presence of an alternative resistance mechanism. Notably, through whole-genome sequencing, we identified a novel mutation C395T in the MMAR_0911 ( grcC1 ) gene that has never been linked to drug resistance. This mutation leads to an A132V substitution in the encoded protein, a polyprenyl diphosphate synthase potentially involved in the synthesis of cell wall components and menaquinones. We found that the overexpression of grcC1 caused resistance to multiple drugs including LZD, clarithromycin (CLR), vancomycin (VAN), clofazimine (CFZ), rifampicin (RIF), cefoxitin (CEF), levofloxacin (LEV), and moxifloxacin (MXF) and reduced cell wall permeability, while the silence and knockout of grcC1 showed increased cell wall permeability and susceptibility to these drugs. Using CRISPR/Cpf1-assisted gene editing, we confirmed that the A132V mutation conferred low-level resistance to the aforementioned drugs in Mycobacterium abscessus and Mycobacterium smegmatis . Furthermore, thin-layer chromatography analysis indicated reduced glycolipid polarity in the grcC1 mutant strains, suggesting an impact on the cell envelope integrity. Our findings suggest that GrcC1 contributes to low-level drug resistance in mycobacteria by potentially reducing cell wall permeability, highlighting its potential as a novel target for antimicrobial agents and as a diagnostic marker. IMPORTANCE Our study uncovers a novel drug resistance mechanism in mycobacteria, focusing on the previously uncharacterized grcC1 gene. We identified a new mutation, A132V, in GrcC1, which is involved in cell wall component synthesis and menaquinone production. This mutation contributes to low-level resistance not only to linezolid but also to a broad range of drugs, including clarithromycin, vancomycin, and rifampicin. Through advanced techniques like CRISPR interference and gene editing, we demonstrated that GrcC1 plays a critical role in drug susceptibility and cell wall permeability across multiple Mycobacterium species. These findings represent the first connection between GrcC1 and drug resistance, offering new insights into combating infections caused by nontuberculous mycobacteria (NTM). Our work highlights the potential of GrcC1 as a target for novel therapeutic approaches and as a diagnostic marker for drug-resistant NTM infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium marinumAnti-Bacterial AgentsMycobacterium smegmatisBacterial ProteinsDrug Resistance, Multiple, BacterialMycobacterium abscessusMicrobial Sensitivity TestsMycobacterium Infections, NontuberculousWhole Genome SequencingMutationCell WallLinezolidHumans

Stichwörter der Autor:innen

GrcC1Mycobacterium abscessusMycobacterium marinumMycobacterium smegmatisdrug resistance mechanism

Substanzen

Anti-Bacterial AgentsBacterial ProteinsLinezolid

Autor:innen und Institutionen

  • State Key Laboratory of Respiratory Disease, Institute of Drug Discovery, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, Guangdong, China.
  • Guangdong-HongKong-Macau Joint Laboratory of Respiratory Infectious Diseases, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, Guangdong, China.
  • University of Chinese Academy of Sciences, Beijing, China.
  • China-New Zealand Belt and Road Joint Laboratory on Biomedicine and Health, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, Guangdong, China.
  • School of Life Sciences, University of Science and Technology of China, Hefei, Anhui, China.
  • Institute of Physical Science and Information Technology, Anhui University, Hefei, Anhui, China.

ORCID-Profile: Cuiting Fang, Yamin Gao, H M Adnan Hameed, Tianyu Zhang

Förderung

  • MOST | National Key Research and Development Program of China (NKPs)
  • State Key Laboratory of Respiratory Disease (SKLRD)
  • Bureau of Science and Information Technology of Guangzhou Municipality | Guangzhou Municipal Science and Technology Project (Guangzhou Science and Technology P…
  • President's International Fellowship Initiative-CAS
  • National Foreign Expert Project
  • Bureau of Science and Information Technology of Guangzhou Municipality | Guangzhou Municipal Science and Technology Project

Zitieren

APA

Fang, C., Zhang, H., He, J., Tian, X., Zeng, S., Han, X., Wang, S., Yusuf, B., Hu, J., Zhong, N., Gao, Y., Hameed, H. M. A., & Zhang, T. (2025). GrcC1 mediates low-level resistance to multiple drugs in M. marinum , M. abscessus, and M. smegmatis. Microbiology Spectrum. https://doi.org/10.1128/spectrum.02289-24

Vancouver

Fang C, Zhang H, He J, Tian X, Zeng S, Han X, et al. GrcC1 mediates low-level resistance to multiple drugs in M. marinum , M. abscessus, and M. smegmatis. Microbiology Spectrum. 2025. doi:10.1128/spectrum.02289-24

BibTeX
@article{Fang2025,
  author = {Fang, Cuiting and Zhang, Han and He, Jing and Tian, Xirong and Zeng, Sanshan and Han, Xingli and Wang, Shuai and Yusuf, Buhari and Hu, Jinxing and Zhong, Nanshan and Gao, Yamin and Hameed, H M Adnan and Zhang, Tianyu},
  title = {GrcC1 mediates low-level resistance to multiple drugs in M. marinum , M. abscessus, and M. smegmatis},
  journal = {Microbiology Spectrum},
  year = {2025},
  doi = {10.1128/spectrum.02289-24}
}
Kostenlos starten →